Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

NCT01755078 is registered in ClinicalTrials.gov with Chugai Pharma Taiwan as lead sponsor.

NCT NCT01755078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01755078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
Lead sponsor
Chugai Pharma Taiwan
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2007
Completion date
June 30, 2009
Enrollment
166 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular events, hemodialysis, hyperphosphatemia